$254.85
Currently 34 wall-street analysts regularly analyze the financials of Alnylam Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 34 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals, Inc. (ALNY) have a share price target of $316.87. This median of share price forecast represents a 24.33% upside from the latest price of $254.85 as on 30.04.25.
As per the chart shown above, analysts believe that the Alnylam Pharmaceuticals, Inc. (ALNY) share price will touch around $316.87 in next 12-months.
Below is a chart showing the percentage difference between Alnylam Pharmaceuticals, Inc.'s share price and its median forecast price. As on 30.04.25, the difference is -19.28%
Based on 34 analysts tracking and researching Alnylam Pharmaceuticals, Inc. (ALNY) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 17 | 16 | 16 |
Outperform | 8 | 8 | 8 |
Hold | 8 | 10 | 10 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |